Improving telehealth delivery of cancer care at home
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
This study is testing if using telehealth can make cancer care at home better for patients with breast and prostate cancer, so they don’t have to go to the hospital as often.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1750 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Trial ID | NCT06954337 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to enhance the delivery of cancer care for patients with breast and prostate cancer by utilizing telehealth services, reducing the need for in-person visits. Conducted at Memorial Sloan Kettering Cancer Center, the study will involve patients who have had multiple prior oncology visits and will assess the effectiveness and safety of this telehealth approach. The trial will implement both physician and patient measures to evaluate outcomes and patient satisfaction with remote care.
Who should consider this trial
Good fit: Ideal candidates are patients with breast or prostate cancer who have had at least three prior medical oncology visits at Memorial Sloan Kettering Cancer Center.
Not a fit: Patients currently enrolled in a therapeutic clinical trial or those whose primary language is not supported by the telehealth system will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve access to cancer care for patients, making it more convenient and less burdensome.
How similar studies have performed: Other studies have shown promising results in utilizing telehealth for cancer care, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits. Exclusion Criteria: * Patient is enrolled on a therapeutic clinical trial. * Patients whose primary language is not currently supported by Epic.
Where this trial is running
Basking Ridge, New Jersey and 6 other locations
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Monmouth (All Protocol Activities) — Middletown, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey, United States (Recruiting)
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) — Commack, New York, United States (Recruiting)
- Memorial Sloan Kettering Westchester (All Protocol Activities) — Harrison, New York, United States (Recruiting)
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) — New York, New York, United States (Recruiting)
- Memorial Sloan Kettering Nassau (All Protocol Activities) — Uniondale, New York, United States (Recruiting)
Study contacts
- Principal investigator: Erin Bange, MD, MSCE — Memorial Sloan Kettering Cancer Center
- Study coordinator: Erin Bange, MD, MSCE
- Email: bangee@mskcc.org
- Phone: 646-422-4680
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.